A detailed history of Westpac Banking Corp transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Westpac Banking Corp holds 1,116 shares of CRL stock, worth $211,292. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,116
Holding current value
$211,292
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$187.96 - $245.29 $209,763 - $273,743
1,116 New
1,116 $220 Million
Q2 2021

Aug 11, 2021

BUY
$294.17 - $371.65 $1.27 Million - $1.6 Million
4,303 New
4,303 $1.59 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.63B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Westpac Banking Corp Portfolio

Follow Westpac Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westpac Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Westpac Banking Corp with notifications on news.